| related words |
| approved |
| clearance |
| recall |
| collaborator |
| commercialization |
| patient |
| indication |
| testing |
| human |
| marketed |
| collaboration |
| drug |
| therapy |
| generic |
| efficacy |
| payors |
| brought |
| pharmaceutical |
| study |
| diagnostic |
|
| related documents |
| 1389072--2/28/2008--HeartWare_LTD |
| 922814--3/31/2006--VIRBAC_CORP |
| 350907--2/24/2010--THORATEC_CORP |
| 357097--4/15/2009--ISOLAGEN_INC |
| 1120438--3/16/2007--THIRD_WAVE_TECHNOLOGIES_INC_/WI |
| 1172480--3/6/2007--SANTARUS_INC |
| 1047699--3/1/2007--KING_PHARMACEUTICALS_INC |
| 946840--3/2/2009--VIROPHARMA_INC |
| 1172480--3/4/2008--SANTARUS_INC |
| 1261302--3/28/2008--ROCKWOOD_SPECIALTIES_GROUP_INC |
| 1261302--3/11/2009--ROCKWOOD_SPECIALTIES_GROUP_INC |
| 1018833--3/14/2008--QUADRAMED_CORP |
| 1338648--2/29/2008--Oracle_Healthcare_Acquisition_Corp. |
| 1366751--3/16/2009--MBF_Healthcare_Acquisition_Corp. |
| 1047699--3/2/2009--KING_PHARMACEUTICALS_INC |
| 874255--2/27/2008--MEDAREX_INC |
| 1366751--3/28/2008--MBF_Healthcare_Acquisition_Corp. |
| 1068796--3/7/2008--MAXYGEN_INC |
| 1047699--2/29/2008--KING_PHARMACEUTICALS_INC |
| 1087432--3/14/2008--INTERMUNE_INC |
|
| related topics |
| {product, liability, claim} |
| {product, candidate, development} |
| {financial, litigation, operation} |
| {cost, contract, operation} |
| {control, financial, internal} |
| {regulation, change, law} |
| {cost, regulation, environmental} |
| {capital, credit, financial} |
| {system, service, information} |
| {acquisition, growth, future} |
| {regulation, government, change} |
| {operation, international, foreign} |
| {condition, economic, financial} |
| {cost, operation, labor} |
| {customer, product, revenue} |
| {personnel, key, retain} |
| {property, intellectual, protect} |
| {stock, price, share} |
| {interest, director, officer} |
| {provision, law, control} |
|